United States
Germany
FranceAbout Dystrophic Epidermolysis Bullosa
What is DEB?
DEB is a serious genetic blistering disease caused by mutations in the COL7A1 gene and can be either dominant (DDEB) or recessive (RDEB) based on inheritance pattern. Both DDEB and RDEB can present with similar dermatologic signs and symptoms and can range in severity, and both have the potential for serious complications.
Testing for DEB
Decode DEB is a no-charge genetic testing program for individuals who are suspected to have epidermolysis bullosa in the U.S. and Puerto Rico. No-charge family variant testing is also available for blood relatives of patients diagnosed with pathogenic or likely pathogenic variants in COL7A1.
Living with DEB
Improving Lives
I was born with blisters but they weren’t what we first thought
Abby, Living with RDEB
We learned Dystrphic EB (DEB) has serious risks. We pushed for answers – for an acurate diagnosis and accurate care
Abby’s Story
Making a Difference
Together, with patients, families, leaders in patient advocacy and some extremely dedicated medical research and gene therapy experts, Krystal is committed to making a difference in the lives of patients.
I live with blisters and nail problems and have been told different reasons why.
Jenny, Living with RDEB
I learned Dystrphic EB (DEB) has serious risks. We pushed for answers – for an acurate diagnosis and accurate care
Jenny’s Story
Krystal Connect is a personalized patient support program designed to help patients and families throughout their treatment journey.
Whether you’re considering treatment, ready to start, or looking for more information about dystrophic epidermolysis buliosa (DEB), Krystal Connect is here to help. When you contact and enroll in Krystal Connect, you will be connected to a dedicated team. Your team is available to:
• Provide education about product and DEB
• Help understand your insurance coverage through benefits investigation
• Support treatment planning and administration
Call 1-844-5-KRYSTAL
for Krystal Connect personalized support
Krystal Connect is a personalized patient support program designed to help patients and families throughout their treatment journey.
Whether considering treatment, ready to start, or looking for more information about dystrophic epidermolysis bullosa (DEB), Krystal Connect is available to help. By contacting and enrolling in Krystal Connect, a dedicated team is available to:
• Provide education about product and DEB
• Help understand your insurance coverage through benefits investigation
• Support treatment planning and administration
Call 1-844-5-KRYSTAL
for Krystal Connect personalized support
Discovering, developing, and commercializing genetic medicines with purpose
